IRIS
MARTORANA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.897
AS - Asia 2.051
EU - Europa 1.996
SA - Sud America 254
AF - Africa 234
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.810
SG - Singapore 834
IT - Italia 761
RU - Federazione Russa 702
CN - Cina 498
BR - Brasile 207
KR - Corea 174
VN - Vietnam 144
BD - Bangladesh 132
IN - India 115
CI - Costa d'Avorio 112
IE - Irlanda 88
FI - Finlandia 69
FR - Francia 66
GB - Regno Unito 52
DE - Germania 51
NG - Nigeria 49
NL - Olanda 48
CA - Canada 39
SE - Svezia 37
MX - Messico 30
SN - Senegal 29
PL - Polonia 28
IQ - Iraq 24
JP - Giappone 23
AR - Argentina 21
CZ - Repubblica Ceca 19
HK - Hong Kong 19
BJ - Benin 18
BE - Belgio 16
ES - Italia 16
UA - Ucraina 14
ID - Indonesia 12
UZ - Uzbekistan 12
TR - Turchia 11
PK - Pakistan 10
ZA - Sudafrica 10
LT - Lituania 9
AE - Emirati Arabi Uniti 7
AT - Austria 6
IR - Iran 6
JM - Giamaica 6
VE - Venezuela 6
CO - Colombia 5
IL - Israele 5
AZ - Azerbaigian 4
CR - Costa Rica 4
EC - Ecuador 4
KE - Kenya 4
OM - Oman 4
TN - Tunisia 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
UY - Uruguay 3
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LB - Libano 2
MA - Marocco 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
TT - Trinidad e Tobago 1
Totale 7.436
Salva come PNG Salva come JPEG
Città #
Dallas 753
Singapore 553
Santa Clara 361
Moscow 329
San Jose 261
Hefei 237
Ashburn 196
Seoul 173
Catania 144
Chicago 137
Los Angeles 123
Chandler 113
Abidjan 112
Dublin 87
Kochi 80
New York 76
Beijing 63
Lauterbourg 59
Boardman 56
Council Bluffs 54
San Giovanni la Punta 47
Palermo 44
Ho Chi Minh City 41
Milan 39
Lappeenranta 37
Rome 35
Hanoi 33
Buffalo 32
Dakar 29
São Paulo 25
Amsterdam 24
Lagos 24
Bari 23
Civitanova Marche 23
Tokyo 23
Warsaw 23
Cambridge 21
Abuja 20
Brno 19
Lawrence 19
Orem 19
Turku 19
Cotonou 18
Hong Kong 18
Munich 18
Naples 17
Brussels 16
Andover 15
Montreal 15
Brooklyn 14
Chennai 13
Helsinki 12
Mexico City 12
Atlanta 11
London 11
Poplar 11
Charlotte 10
Florence 10
Manchester 10
Seattle 10
Stockholm 10
Tashkent 10
Wilmington 10
Da Nang 9
Denver 9
Des Moines 9
Johannesburg 9
Phoenix 9
Baghdad 8
Bremen 8
Columbus 8
Cosenza 8
Houston 8
Messina 8
San Francisco 8
Santa Venerina 8
Aci Catena 7
Frankfurt am Main 7
Grafing 7
Grammichele 7
The Dalles 7
Toronto 7
Haiphong 6
Paternò 6
Pisa 6
Querétaro 6
Tehran 6
Ankara 5
Brescia 5
Genoa 5
Jacksonville 5
Port Harcourt 5
Belo Horizonte 4
Belpasso 4
Dong Ket 4
Jakarta 4
Kingston 4
Mascalucia 4
Mumbai 4
Palagiano 4
Totale 5.095
Salva come PNG Salva come JPEG
Nome #
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 265
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 220
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 208
Drivers of choice and outcomes of breast-conserving surgery versus mastectomy in breast cancer patients with complete response following neoadjuvant therapy: a retrospective analysis from the EUSOMA database 200
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 194
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 184
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 182
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 177
Biomarkers and prognostic factors for malignant pleural mesothelioma 169
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 155
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 151
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 145
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 141
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 138
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 137
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 133
Orbital metastasis from thyroid cancer: a case report and review of the literature 132
Opportunities and challenges of liquid biopsy in thyroid cancer 131
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 130
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 130
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 128
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 125
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 124
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 124
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 122
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 121
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 120
Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study 115
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 115
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 111
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases 108
Implications of antidepressants use in breast cancer: A brief review 107
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 105
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 104
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 101
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive 101
Nasopharyngeal Metastasis from Lung Adenocarcinoma: A Case Report and Literature Review 100
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 98
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer 98
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors 93
REThinking the role of the RET oncogene in breast cancer 88
Unveiling Prostate-Specific Membrane Antigen’s Potential in Breast Cancer Management 88
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 86
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma 83
Profilo Molecolare in una Coorte di Neoplasie Tiroidee Insorte nell'Area Vulcanica della Sicilia 82
Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study 80
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer 80
Type 2 diabetes and cancer: problems and suggestions for best patient management 78
Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study 74
Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents 73
Ribociclib efficacy in special populations and analysis of patient reported outcomes in the MONALEESA trials 73
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 72
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer 72
Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database 71
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities 71
Phase I dose-escalation study of the dual PI3K-mTORC1/2 inhibitor gedatolisib in combination with paclitaxel and carboplatin in patients with advanced solid tumors 71
Prognostic value of the interval between the last neoadjuvant chemotherapy (CT) administration and breast surgery: Preliminary data of the NeoBracer international observational study 69
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2– breast cancer patients: a retrospective study 69
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 66
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review 65
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review 64
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer 61
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project 59
A systematic review of phase I trials in patients with ovarian cancer 59
Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story 56
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer 47
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions 44
Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer 38
Reply to: EUSOMA and NCCN should include clinical staging after neoadjuvant therapy as a quality indicator for treatment guidance 36
Radiomics in cervical and endometrial cancer 20
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review 2
Totale 7.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022118 1 14 2 2 21 2 19 3 6 5 12 31
2022/2023429 24 23 21 50 20 60 13 83 85 7 25 18
2023/2024337 43 52 16 12 11 66 3 15 2 19 45 53
2024/20251.617 43 187 81 74 238 224 72 65 67 122 266 178
2025/20264.882 252 455 859 278 642 901 443 87 228 264 311 162
2026/202770 70 0 0 0 0 0 0 0 0 0 0 0
Totale 7.539